FCGR3B: A Potential Drug Target and Biomarker for Neurological Disorders

Target Name: FCGR3B

NCBI ID: G2215

FCGR3B: A Potential Drug Target and Biomarker for Neurological Disorders

FCGR3B (FCG3B_HUMAN), also known as GFR伪1b, is a protein that is expressed in various tissues of the human body, including the brain, heart, kidneys, and liver. It is a member of the G-protein-coupled receptor (GPCR) family, which is a large family of transmembrane proteins that play a critical role in cellular signaling.

FCGR3B is a 21-kDa protein that is expressed in the brain, heart, and kidneys. It is highly expressed in the brain, with higher levels of expression in the prefrontal cortex, basal ganglia, and hippocampus compared to other regions of the brain.FCGR3B is also expressed in other tissues, including the kidneys and liver, and has been shown to be involved in a variety of physiological processes, including neurotransmitter signaling, ion homeostasis, and cell survival.

One of the most promising aspects of FCGR3B is its potential as a drug target.FCGR3B has been shown to play a role in a variety of neurotransmitter signaling pathways, including the regulation of dopamine (DA) and serotonin (5-HT) release. It is also involved in the regulation of ion homeostasis, including the maintenance of brain ion levels during times of stress. In addition, FCGR3B has been shown to play a role in cell survival and has been shown to protect against various forms of cellular stress, including oxidative stress and neurotoxic stress.

FCGR3B is also a potential biomarker for a variety of neurological and psychiatric disorders.Studies have shown that FCGR3B is often reduced in individuals with conditions such as Alzheimer's disease, Parkinson's disease, and depression. Additionally, FCGR3B has been shown to be involved in the development of certain psychiatric disorders, including anxiety and schizophrenia. These findings suggest that FCGR3B may be a promising target for the development of new treatments for a variety of neurological and psychiatric disorders.

In conclusion, FCGR3B is a protein that is expressed in various tissues of the human body and is involved in a variety of physiological processes, including neurotransmitter signaling, ion homeostasis, and cell survival. Its potential as a drug target and as a biomarker for neurological and psychiatric disorders makes it an attractive target for further research and development. Further studies are needed to fully understand the role of FCGR3B in cellular signaling and its potential as a drug and biomarker.

Protein Name: Fc Gamma Receptor IIIb

Functions: Receptor for the Fc region of immunoglobulins gamma. Low affinity receptor. Binds complexed or aggregated IgG and also monomeric IgG. Contrary to III-A, is not capable to mediate antibody-dependent cytotoxicity and phagocytosis. May serve as a trap for immune complexes in the peripheral circulation which does not activate neutrophils

More Common Targets